1 line
No EOL
38 KiB
Text
1 line
No EOL
38 KiB
Text
{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T13:41:56Z","timestamp":1700746916354},"reference-count":112,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:p>Equine veterinarians face challenges in treating horses with osteoarthritic joint pain in routine veterinary practice. All common treatment options aim to reduce the clinical consequences of osteoarthritis (OA) characterized by persistent synovitis and progressive degradation of articular cartilage. A range of joint-associated cell types and extracellular matrices are involved in the not yet entirely understood chronic inflammatory process. Regeneration of articular tissues to re-establish joint hemostasis is the future perspective when fundamental healing of OA is the long-term goal. The use of intra-articular applied biologic therapeutics derived from blood or mesenchymal stroma cell (MSC) sources is nowadays a well-accepted treatment option. Although this group of therapeutics is not totally consistent due to the lack of clear definitions and compositions, they all share a potential regenerative effect on articular tissues as described in <jats:italic>in vivo<\/jats:italic> and <jats:italic>in vitro<\/jats:italic> studies. However, the current stage of science in regenerative medicine needs to be supported by clinical reports as in fact, <jats:italic>in vitro<\/jats:italic> studies as well as studies using induced OA models still represent a fragment of the complex pathomechanism of naturally occurring OA. This systemic review aims to determine the long-term effect of orthobiologic therapeutics in horses suffering naturally occurring OA. Thereby, a meta-analysis of randomized controlled trials (RCTs) is conducted to describe the efficiency and safety of intra-articular applied orthobiologics in terms of lameness reduction in the long-term. Using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) guidelines, thirteen studies met the inclusion criteria for the systemic review. Four of those studies have further been evaluated by the meta-analysis comparing the long-term effect in lameness reduction. Each study was examined for risk of bias. For data evaluation, a random-effects model was used, describing the overall outcome in a forest plot. The I<jats:sup>2<\/jats:sup> statistic was used to assess heterogeneity. Results indicate, that orthobiologic therapies represent an effective long-term and safe OA treatment option. Due to the inhomogeneity of included studies, no statements are provided addressing specific orthobiologic therapies, affected joints, OA stage and horse's intended use. Future clinical trials should follow standardized study designs to provide comparable data.<\/jats:p>","DOI":"10.3389\/fvets.2023.1125695","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T09:41:53Z","timestamp":1677145313000},"update-policy":"http:\/\/dx.doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Systematic review and meta-analysis of positive long-term effects after intra-articular administration of orthobiologic therapeutics in horses with naturally occurring osteoarthritis"],"prefix":"10.3389","volume":"10","author":[{"given":"Anna","family":"Mayet","sequence":"first","affiliation":[]},{"given":"Yury","family":"Zablotski","sequence":"additional","affiliation":[]},{"given":"Susanne Pauline","family":"Roth","sequence":"additional","affiliation":[]},{"given":"Walter","family":"Brehm","sequence":"additional","affiliation":[]},{"given":"Antonia","family":"Troillet","sequence":"additional","affiliation":[]}],"member":"1965","published-online":{"date-parts":[[2023,2,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13018-016-0346-5","article-title":"Animal models of osteoarthritis: classification, update, and measurement of outcomes","volume":"11","author":"Kuyinu","year":"2016","journal-title":"J Orthop Surg Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1177\/0300985815588611","article-title":"Animal models of osteoarthritis: comparisons and key considerations","volume":"52","author":"McCoy","year":"2015","journal-title":"Vet Pathol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.3390\/cells8111305","article-title":"Articular cartilage regeneration in osteoarthritis","volume":"8","author":"Roseti","year":"2019","journal-title":"Cells"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.3390\/ani11113247","article-title":"Role of Innate immunity in initiation and progression of osteoarthritis, with emphasis on horses","volume":"11","author":"Estrada Mcdermott","year":"2021","journal-title":"Animals"},{"key":"B5","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/B978-0-7216-8342-3.50092-9","article-title":"Principles and Practices of Joint Disease Treatment","volume-title":"Diagnosis and Management of Lameness in the Horse","author":"Caron","year":"2003"},{"key":"B6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.21608\/svu.2021.57242.1099","article-title":"Equine osteoarthritis: an overview of different treatment strategies","volume":"4","author":"Mahmoud","year":"2021","journal-title":"SVU Int J Vet Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.cveq.2016.04.003","article-title":"Musculoskeletal disease in aged horses and its management","volume":"32","author":"van Weeren","year":"2016","journal-title":"Vet Clin North Am Equine Pract."},{"key":"B8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.2042-3306.1991.tb02749.x","article-title":"Clinical evaluation of poor performance in the racehorse: the results of 275 evaluations","volume":"23","author":"Morris","year":"1991","journal-title":"Equine Vet J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12917-016-0687-7","article-title":"A randomised, double-blinded, placebo-controlled clinical study on intra-articular hyaluronan treatment in equine lameness originating from the metacarpophalangeal joint","volume":"12","author":"Niemel\u00e4","year":"2016","journal-title":"BMC Vet Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.2460\/ajvr.71.11.1284","article-title":"Determination of the prevalence and severity of metacarpophalangeal joint osteoarthritis in Thoroughbred racehorses via quantitative macroscopic evaluation","volume":"71","author":"Neundorf","year":"2010","journal-title":"Am J Vet Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12917-016-0873-7","article-title":"Pro-inflammatory cytokines and structural biomarkers are effective to categorize osteoarthritis phenotype and progression in Standardbred racehorses over five years of racing career","volume":"12","author":"Bertuglia","year":"2016","journal-title":"BMC Vet Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/j.1532-950X.1981.tb00635.x","article-title":"Treatment of degenerative joint disease of the horse: a review and commentary","volume":"10","author":"Auer","year":"1981","journal-title":"Vet Surg."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.4142\/jvs.2020.21.e21","article-title":"Ultrasound and clinical findings in the metacarpophalangeal joint assessment of show jumping horses in training","volume":"21","author":"Yamada","year":"2020","journal-title":"J Vet Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/af\/vfac026","article-title":"Osteoarthritis: a common disease that should be avoided in the athletic horse's life","volume":"12","author":"Baccarin","year":"2022","journal-title":"Anim Front Rev Mag Anim Agric."},{"key":"B15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1302\/2046-3758.111.2000132","article-title":"The horse as a model of naturally occurring osteoarthritis","volume":"1","author":"McIlwraith","year":"2012","journal-title":"Bone Joint Res."},{"key":"B16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.2042-3306.1999.tb03794.x","article-title":"Naturally occurring osteoarthritis in the metacarpophalangeal joints of wild horses","volume":"31","author":"Cantley","year":"1999","journal-title":"Equine Vet J."},{"key":"B17","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1111\/j.1532-950X.2009.00589.x","article-title":"Carpometacarpal osteoarthritis in thirty-three horses","volume":"38","author":"Panizzi","year":"2009","journal-title":"Vet Surg."},{"key":"B18","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1532-950X.2014.12100.x","article-title":"Clinical outcome after intra-articular administration of bone marrow derived mesenchymal stem cells in 33 horses with stifle injury","volume":"43","author":"Ferris","year":"2014","journal-title":"Vet Surg."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.4102\/jsava.v90i0.1721","article-title":"Clinical findings, synovial fluid cytology and growth factor concentrations after intra-articular use of a platelet-rich product in horses with osteoarthritis","volume":"90","author":"Smit","year":"2019","journal-title":"J S Afr Vet Assoc."},{"key":"B20","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1016\/j.joca.2010.05.031","article-title":"The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the horse","volume":"18","author":"McIlwraith","year":"2010","journal-title":"Osteoarthr Cartil"},{"key":"B21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.tvjl.2004.07.008","article-title":"Medical treatment of osteoarthritis in the horse - a review","volume":"171","author":"Goodrich","year":"2006","journal-title":"Vet J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.cveq.2018.04.007","article-title":"Management and rehabilitation of joint disease in sport horses","volume":"34","author":"Contino","year":"2018","journal-title":"Vet Clin North Am Equine Pract."},{"key":"B23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12917-016-0759-8","article-title":"In vitro effects of platelet-rich gel supernatants on histology and chondrocyte apoptosis scores, hyaluronan release and gene expression of equine cartilage explants challenged with lipopolysaccharide","volume":"12","author":"Carmona","year":"2016","journal-title":"BMC Vet Res"},{"key":"B24","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1089\/scd.2016.0266","article-title":"Autologous and allogeneic equine mesenchymal stem cells exhibit equivalent immunomodulatory properties in vitro","volume":"26","author":"Colbath","year":"2017","journal-title":"Stem Cells Dev."},{"key":"B25","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3389\/fphar.2019.00699","article-title":"Conditioned serum enhances the chondrogenic and immunomodulatory behavior of mesenchymal stem cells","volume":"10","author":"Bl\u00e1zquez","year":"2019","journal-title":"Front Pharmacol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/j.2042-3306.2010.00321.x","article-title":"Autologous conditioned serum: the comparative cytokine profiles of two commercial methods (IRAP and IRAP II) using equine blood","volume":"43","author":"Hraha","year":"2011","journal-title":"Equine Vet J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"218","DOI":"10.4236\/scd.2013.34027","article-title":"Mesenchymal stem cell enhances chondral defects healing in horses","volume":"3","author":"Yamada","year":"2013","journal-title":"Stem Cell Discov."},{"key":"B28","doi-asserted-by":"publisher","first-page":"S222","DOI":"10.1016\/S1063-4584(08)60559-2","article-title":"520 evaluation of autologous conditioned serum using an experimental model of equine osteoarthritis","volume":"16","author":"Frisbie","year":"2008","journal-title":"Osteoarthr Cartil."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/j.arthro.2011.06.002","article-title":"Evaluation of intra-articular mesenchymal stem cells to augment healing of microfractured chondral defects","volume":"27","author":"McIlwraith","year":"2011","journal-title":"Arthroscopy."},{"key":"B30","doi-asserted-by":"publisher","first-page":"290","DOI":"10.2460\/ajvr.68.3.290","article-title":"Clinical, biochemical, and histologic effects of intra-articular administration of autologous conditioned serum in horses with experimentally induced osteoarthritis","volume":"68","author":"Frisbie","year":"2007","journal-title":"Am J Vet Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e0221317","DOI":"10.1371\/journal.pone.0221317","article-title":"Comparison of efficacy and safety of single versus repeated intra-articular injection of allogeneic neonatal mesenchymal stem cells for treatment of osteoarthritis of the metacarpophalangeal\/metatarsophalangeal joint in horses: a clinical pilot study","volume":"14","author":"Magri","year":"2019","journal-title":"PLoS ONE"},{"key":"B32","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jevs.2007.02.007","article-title":"Autologous platelet concentrates as a treatment of horses with osteoarthritis: a preliminary pilot clinical study","volume":"27","author":"Carmona","year":"2007","journal-title":"J Equine Vet Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fvets.2021.602978","article-title":"A comparative review of autologous conditioned serum and autologous protein solution for treatment of osteoarthritis in horses","volume":"8","author":"Camargo Garbin","year":"2021","journal-title":"Front Vet Sci."},{"key":"B34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.5551\/jat.13.77","article-title":"Adipose tissue-derived stromal cells as a novel option for regenerative cell therapy","volume":"13","author":"Nakagami","year":"2006","journal-title":"J Atheroscler Thromb."},{"key":"B35","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3389\/fbioe.2022.855095","article-title":"in tendon and joint disease: the context-sensitive link between targets and therapeutic mechanisms","volume":"10","author":"Roth","year":"2022","journal-title":"Front Bioeng Biotechnol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1002\/sctm.20-0552","article-title":"Allogeneic mesenchymal stromal cells for cartilage regeneration: a review of in vitro evaluation, clinical experience, and translational opportunities","volume":"10","author":"Aldrich","year":"2021","journal-title":"Stem Cells Transl Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1177\/0885328213492573","article-title":"Platelet-rich plasma combined with agarose as a bioactive scaffold to enhance cartilage repair: an in vitro study","volume":"28","author":"Yin","year":"2014","journal-title":"J Biomater Appl."},{"key":"B38","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1002\/art.11365","article-title":"Stem cell therapy in a caprine model of osteoarthritis","volume":"48","author":"Murphy","year":"2003","journal-title":"Arthritis Rheum."},{"key":"B39","doi-asserted-by":"publisher","first-page":"510","DOI":"10.3389\/fvets.2020.00510","article-title":"Regenerative approach to canine osteoarthritis using allogeneic, adipose-derived mesenchymal stem cells. Safety results of a long-term follow-up","volume":"7","author":"Kriston-P\u00e1l","year":"2020","journal-title":"Front Vet Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2174\/1574888X09666140826110601","article-title":"Allogenic mesenchymal stem cells as a treatment for equine degenerative joint disease: a pilot study","volume":"9","author":"Broeckx","year":"2014","journal-title":"Curr Stem Cell Res Ther."},{"key":"B41","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1055\/a-1482-7752","article-title":"Cell-based therapeutic strategies for osteoarthritis in equine patients: Basic knowledge for clinical practitioners","volume":"49","author":"Roth","year":"2021","journal-title":"Tierarztl Prax Ausgabe G Grosstiere Nutztiere."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fvets.2018.00070","article-title":"Cell-based therapies for joint disease in veterinary medicine: what we have learned and what we need to know","volume":"5","author":"Bogers","year":"2018","journal-title":"Front Vet Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3389\/fvets.2020.00278","article-title":"stem cells in veterinary medicine\u2014current state and treatment options","volume":"7","author":"Voga","year":"2020","journal-title":"Front Vet Sci"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5704\/MOJ.1511.016","article-title":"The current role of stem cells in orthopaedic surgery","volume":"9","author":"Maniar","year":"2015","journal-title":"Malaysian Orthop J."},{"key":"B45","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2174\/1566523220999200818115803","article-title":"The emerging role of stem cells in regenerative dentistry","volume":"20","author":"Cappar\u00e8","year":"2020","journal-title":"Curr Gene Ther."},{"key":"B46","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/1471-2474-12-259","article-title":"Homing and reparative effect of intra-articular injection of autologus mesenchymal stem cells in osteoarthritic animal model","volume":"12","author":"Mokbel","year":"2011","journal-title":"BMC Musculoskelet Disord"},{"key":"B47","doi-asserted-by":"publisher","first-page":"CD007888","DOI":"10.1002\/14651858.CD007888.pub2","article-title":"Stem cell therapy for chronic ischaemic heart disease and congestive heart failure","volume":"2014","author":"Fisher","year":"2014","journal-title":"Cochrane database Syst Rev"},{"key":"B48","doi-asserted-by":"publisher","first-page":"106416","DOI":"10.1016\/j.clineuro.2020.106416","article-title":"Stem cell therapy in patients with epilepsy: a systematic review","volume":"200","author":"Aligholi","year":"2021","journal-title":"Clin Neurol Neurosurg"},{"key":"B49","doi-asserted-by":"publisher","first-page":"507","DOI":"10.3389\/fvets.2019.00507","article-title":"The potential of mesenchymal stem cells to treat systemic inflammation in horses","volume":"6","author":"MacDonald","year":"2020","journal-title":"Front Vet Sci."},{"key":"B50","first-page":"448","article-title":"Mesenchymal stem cells in osteoarthritis therapy: a review","volume":"13","author":"Zhu","year":"2021","journal-title":"Am J Transl Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/14653240500319234","article-title":"Clarification of the nomenclature for MSC: the international society for cellular therapy position statement","volume":"7","author":"Horwitz","year":"2005","journal-title":"Cytotherapy."},{"key":"B52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.stem.2011.06.008","article-title":"The MSC: an injury drugstore","volume":"9","author":"Caplan","year":"2011","journal-title":"Cell Stem Cell."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1002\/sctm.17-0051","article-title":"Mesenchymal stem cells: time to change the name!","volume":"6","author":"Caplan","year":"2017","journal-title":"Stem Cells Transl Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/eve.12398","article-title":"Ultrasound-guided lipoaspiration for mesenchymal stromal cell harvest in the horse","volume":"28","author":"Lawver","year":"2016","journal-title":"Equine Vet Educ."},{"key":"B55","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1089\/scd.2018.0074","article-title":"Allogeneic adipose-derived mesenchymal stem cells (Horse Allo 20) for the treatment of osteoarthritis-associated lameness in horses: Characterization, safety, and efficacy of intra-articular treatment","volume":"27","author":"Mari\u00f1as-Pardo","year":"2018","journal-title":"Stem Cells Dev."},{"key":"B56","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00441-011-1316-1","article-title":"Stem cell-based tissue engineering in veterinary orthopaedics","volume":"347","author":"Brehm","year":"2012","journal-title":"Cell Tissue Res."},{"key":"B57","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/evj.13089","article-title":"The use of equine chondrogenic-induced mesenchymal stem cells as a treatment for osteoarthritis: a randomised, double-blinded, placebo-controlled proof-of-concept study","volume":"51","author":"Broeckx","year":"2019","journal-title":"Equine Vet J."},{"key":"B58","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.rvsc.2017.12.018","article-title":"Equine allogeneic chondrogenic induced mesenchymal stem cells: a GCP target animal safety and biodistribution study","volume":"117","author":"Broeckx","year":"2018","journal-title":"Res Vet Sci."},{"key":"B59","unstructured":"Arti-Cell Forte (Chondrogenic Induced Equine Allogeneic Peripheral Blood-Derived Mesenchymal Stem Cells).2018"},{"key":"B60","unstructured":"HorStem (Equine Umbilical Cord Mesenchymal Stem Cells) What is HorStem and what is it used for? How is HorStem used? How does HorStem work?2019"},{"key":"B61","volume-title":"Efficacy and safety study of allogeneic Equine Umbilical Cord derived Mesenchymal Stem Cells (EUC-MSCs) for the treatment of clinical symptomatology associated with mild to moderate degenerative joint disease (osteoarthritis) in horses under field conditions","author":"Pradera","year":"2019"},{"key":"B62","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.tvjl.2013.04.018","article-title":"Therapeutic use of stem cells in horses: which type, how, and when?","volume":"197","author":"Schnabel L","year":"2013","journal-title":"Vet J."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.jevs.2014.06.023","article-title":"Characterization of nucleated cells from equine adipose tissue and bone marrow aspirate processed for point-of-care use","volume":"34","author":"Bruno","year":"2014","journal-title":"J Equine Vet Sci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.cveq.2011.05.003","article-title":"Collection and propagation methods for mesenchymal stromal cells","volume":"27","author":"Taylor","year":"2011","journal-title":"Vet Clin North Am Equine Pract."},{"key":"B65","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1080\/14653240902887259","article-title":"Improved isolation protocol for equine cord blood-derived mesenchymal stromal cells","volume":"11","author":"Koch","year":"2009","journal-title":"Cytotherapy."},{"key":"B66","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/j.2042-3306.2010.00098.x","article-title":"Isolation of equine bone marrow-derived mesenchymal stem cells: a comparison between three protocols","volume":"42","author":"Bourzac","year":"2010","journal-title":"Equine Vet J."},{"key":"B67","doi-asserted-by":"publisher","first-page":"898","DOI":"10.2460\/ajvr.77.8.898","article-title":"Comparison of humoral insulin-like growth factor-1, platelet-derived growth factor-BB, transforming growth factor-\u03b21, and interleukin-1 receptor antagonist concentrations among equine autologous blood-derived preparations","volume":"77","author":"Ionita","year":"2016","journal-title":"Am J Vet Res."},{"key":"B68","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/evj.12288","article-title":"Equine autologous platelet concentrates: a comparative study between different available systems","volume":"47","author":"Hessel","year":"2015","journal-title":"Equine Vet J."},{"key":"B69","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cveq.2011.05.001","article-title":"Autologous biologic treatment for equine musculoskeletal injuries: platelet-rich plasma and IL-1 receptor antagonist protein","volume":"27","author":"Textor","year":"2011","journal-title":"Vet Clin North Am Equine Pract."},{"key":"B70","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12917-015-0403-z","article-title":"Platelet-rich plasma in orthopedic therapy: a comparative systematic review of clinical and experimental data in equine and human musculoskeletal lesions","volume":"11","author":"Brossi","year":"2015","journal-title":"BMC Vet Res"},{"key":"B71","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s40781-018-0178-4","article-title":"Comparison of the methods for platelet rich plasma preparation in horses","volume":"60","author":"Lee","year":"2018","journal-title":"J Anim Sci Technol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.tvjl.2013.07.020","article-title":"Synovial fluid growth factor and cytokine concentrations after intra-articular injection of a platelet-rich product in horses","volume":"198","author":"Textor","year":"2013","journal-title":"Vet J."},{"key":"B73","doi-asserted-by":"publisher","first-page":"159","DOI":"10.12998\/wjcc.v5.i5.159","article-title":"Evolution, current status and advances in application of platelet concentrate in periodontics and implantology","volume":"5","author":"Agrawal","year":"2017","journal-title":"World J Clin Cases."},{"key":"B74","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/00008505-200110000-00002","article-title":"Platelet-rich plasma (PRP): what is PRP and what is not PRP?","volume":"10","author":"Marx","year":"2001","journal-title":"Implant Dent."},{"key":"B75","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2460\/ajvr.75.2.141","article-title":"Evaluation of a single intra-articular injection of autologous protein solution for treatment of osteoarthritis in horses","volume":"75","author":"Bertone","year":"2014","journal-title":"Am J Vet Res."},{"key":"B76","doi-asserted-by":"publisher","first-page":"579967","DOI":"10.3389\/fvets.2020.579967","article-title":"A Survey of Clinical Usage of Non-steroidal Intra-Articular Therapeutics by Equine Practitioners","volume":"7","author":"Velloso Alvarez","year":"2020","journal-title":"Front Vet Sci"},{"key":"B77","doi-asserted-by":"publisher","first-page":"e85917","DOI":"10.1371\/journal.pone.0085917","article-title":"Regenerative therapies for equine degenerative joint disease: a preliminary study","volume":"9","author":"Broeckx","year":"2014","journal-title":"PLoS ONE"},{"key":"B78","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13287-015-0115-0","article-title":"Effect of a single injection of autologous conditioned serum (ACS) on tendon healing in equine naturally occurring tendinopathies","volume":"6","author":"Geburek","year":"2015","journal-title":"Stem Cell Res Ther"},{"key":"B79","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s00011-003-1197-1","article-title":"The production of anti-inflammatory cytokines in whole blood by physico-chemical induction","volume":"52","author":"Meijer","year":"2003","journal-title":"Inflamm Res."},{"key":"B80","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2165\/00063030-200721050-00004","article-title":"Autologous Conditioned Serum in the Treatment of Orthopedic Diseases","volume":"21","author":"Wehling","year":"2012","journal-title":"BioDrugs"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12917-020-02391-7","article-title":"Is clinical effect of autologous conditioned serum in spontaneously occurring equine articular lameness related to ACS cytokine profile?","volume":"16","author":"Marques-Smith","year":"2020","journal-title":"BMC Vet Res."},{"key":"B82","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/sj.gt.3301608","article-title":"Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene","volume":"9","author":"Frisbie","year":"2002","journal-title":"Gene Ther."},{"key":"B83","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jevs.2016.09.014","article-title":"Evaluation of two protocols using autologous conditioned serum for intra-articular therapy of equine osteoarthritis\u2014A pilot study monitoring cytokines and cartilage-specific biomarkers","volume":"60","author":"Lasarzik","year":"2018","journal-title":"J Equine Vet Sci"},{"key":"B84","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ijsu.2018.02.065","article-title":"Comparison of intra-articular hyaluronic acid and methylprednisolone for pain management in knee osteoarthritis: a meta-analysis of randomized controlled trials","volume":"53","author":"Ran","year":"2018","journal-title":"Int J Surg."},{"key":"B85","volume-title":"Metaanalyse klinischer Studien 1983-2016 zur langfristigen Gebrauchsf\u00e4higkeit von Sportpferden nach Behandlung von nat\u00fcrlich entstandenen Erkrankungen der oberfl\u00e4chlichen und der tiefen Beugesehne und des Fesseltr\u00e4gers entweder allein mit kontrollierter Bewegung oder kombiniert mit einem potenziell regenerativen Therapeutikum","author":"Doll","year":"2019"},{"key":"B86","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1089\/scd.2018.0061","article-title":"Equine allogeneic chondrogenic induced mesenchymal stem cells are an effective treatment for degenerative joint disease in horses","volume":"28","author":"Broeckx","year":"2019","journal-title":"Stem Cells Dev."},{"key":"B87","doi-asserted-by":"publisher","first-page":"196","DOI":"10.21836\/PEM20200301","article-title":"A prospective comparison of the GOLDIC \u00ae technique and corticosteroid plus hyaluronic acid injections for arthrogenic lameness in horses","volume":"36","author":"F\u00fcrst","year":"2020","journal-title":"Medicine (Baltimore)."},{"key":"B88","doi-asserted-by":"publisher","first-page":"241","DOI":"10.21836\/PEM20160307","article-title":"Behandlung von osteoarthritis mit ACS (IRAP\u00ae) bei 26 pferden-retrospektive studie","volume":"32","author":"Warner","year":"2016","journal-title":"Pferdeheilkunde."},{"key":"B89","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1080\/01652176.2016.1141257","article-title":"Evaluation of intra-articular injection of autologous platelet lysate (PL) in horses with osteoarthritis of the distal interphalangeal joint","volume":"36","author":"Tyrnenopoulou","year":"2016","journal-title":"Vet Q."},{"key":"B90","doi-asserted-by":"publisher","first-page":"198","DOI":"10.11138\/mltj\/2016.6.2.198","article-title":"Combined use of platelet rich plasma & micro-fat in sport and race horses with degenerative joint disease: Preliminary clinical study in eight horses","volume":"6","author":"Bembo","year":"2016","journal-title":"Muscles Ligaments Tendons J."},{"key":"B91","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jevs.2013.10.004","article-title":"Autologous platelet concentrate as a treatment for horses with refractory fetlock osteoarthritis","volume":"34","author":"Pichereau","year":"2014","journal-title":"J Equine Vet Sci."},{"key":"B92","volume-title":"Vergleichende Betrachtung des Behandlungserfolges der intraartikul\u00e4ren kombinierten Behandlung mit Natriumhyaluronat und Betamethason mit der intraartikul\u00e4ren Behandlung mit autologem konditionierten Serum (IL-1 Ra) bei Pferden mit positiver Hufgelenkan\u00e4sthesie- Eine Anwendungsbeobachtung","author":"J\u00f6stingmeier","year":"2009"},{"key":"B93","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"B94","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"B95","unstructured":"R: A Language Environment for Statistical Computing2022"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1136\/bmj.322.7300.1479","article-title":"Forest plots: trying to see the wood and the trees","volume":"322","author":"Lewis","year":"2001","journal-title":"BMJ Br Med J."},{"key":"B97","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1177\/21925682211003889","article-title":"Seeing the forest by looking at the trees: how to interpret a meta-analysisforest plot","volume":"11","author":"Dettori","year":"2021","journal-title":"Glob Spine J."},{"key":"B98","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2021","journal-title":"Res Synth Methods."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12917-018-1556-3","article-title":"Assessment of effectiveness and safety of repeat administration of proinflammatory primed allogeneic mesenchymal stem cells in an equine model of chemically induced osteoarthritis","volume":"14","author":"Barrachina","year":"2018","journal-title":"BMC Vet Res."},{"key":"B100","doi-asserted-by":"publisher","first-page":"S222","DOI":"10.1016\/S1063-4584(08)60558-0","article-title":"519 evaluation of bone marrow derived stem cells and adipose derived stromal vascular fraction for treatment of osteoarthritis using an equine experimental model","volume":"16","author":"Frisbie","year":"2008","journal-title":"Osteoarthr Cartil."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1002\/jor.20933","article-title":"Evaluation of adipose-derived stromal vascular fraction or bone marrow-derived mesenchymal stem cells for treatment of osteoarthritis","volume":"27","author":"Frisbie","year":"2009","journal-title":"J Orthop Res."},{"key":"B102","doi-asserted-by":"publisher","first-page":"753","DOI":"10.2478\/pjvs-2013-0107","article-title":"Therapeutic effect of adipose-derived mesenchymal stem cell injection in horses suffering from bone spavin","volume":"16","author":"Nicpo\u0144","year":"2013","journal-title":"Pol J Vet Sci."},{"key":"B103","unstructured":"Intraarticular platelet rich plasma (PRP) therapy: Evaluation in 42 sport horse with OA\n AbellanetI\n PadresM\n 2009"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fvets.2016.00029","article-title":"Gait changes vary among horses with naturally occurring osteoarthritis following intra-articular administration of autologous platelet-rich plasma","volume":"3","author":"Mirza","year":"2016","journal-title":"Front Vet Sci."},{"key":"B105","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1055\/s-0029-1225792","article-title":"Klinische Erfahrungen mit der Anwendung von ACS\/ORTHOKIN\/IRAP beim Pferd","volume":"11","author":"Weinberger","year":"2008","journal-title":"Pferde Spiegel."},{"key":"B106","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1037\/a0027128","article-title":"Publication bias in psychological science: comment on Ferguson and Brannick","volume":"17","author":"Rothstein","year":"2012","journal-title":"Psychol Methods."},{"key":"B107","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/jor.21359","article-title":"Post-traumatic osteoarthritis: Improved understanding and opportunities for early intervention","volume":"29","author":"Anderson","year":"2011","journal-title":"J Orthop Res."},{"key":"B108","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jcot.2018.08.019","article-title":"Innovative regenerative medicine in the management of knee OA: the role of autologous protein solution","volume":"10","author":"Vitale","year":"2019","journal-title":"J Clin Orthop Trauma."},{"key":"B109","doi-asserted-by":"publisher","first-page":"982199","DOI":"10.3389\/fcell.2022.982199","article-title":"Updates on mesenchymal stem cell therapies for articular cartilage regeneration in large animal models","volume":"10","author":"Liu","year":"2022","journal-title":"Front cell Dev Biol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ani11030793","article-title":"The use of platelet-rich plasma for treatment of tenodesmic lesions in horses: a systematic review and meta-analysis of clinical and experimental data","volume":"11","author":"Montano","year":"2021","journal-title":"Animals."},{"key":"B111","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/S0140-6736(02)07816-9","article-title":"Blinding in randomised trials: hiding who got what","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet."},{"key":"B112","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.cct.2010.11.004","article-title":"The blind leading the blind: Use and misuse of blinding in randomized controlled trials","volume":"32","author":"Miller","year":"2011","journal-title":"Contemp Clin Trials."}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2023.1125695\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T09:42:00Z","timestamp":1677145320000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2023.1125695\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,23]]},"references-count":112,"alternative-id":["10.3389\/fvets.2023.1125695"],"URL":"http:\/\/dx.doi.org\/10.3389\/fvets.2023.1125695","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":["General Veterinary"],"published":{"date-parts":[[2023,2,23]]}}} |